文献速递冠心病血脂与心血管预防

ADCY9 失活仅在 CETP 缺失时抗动脉粥样硬化

ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
PubMed 文献 · Circulation · 2018-01-01

本研究在 Adcy9 失活小鼠及 CETP 转基因小鼠中采用 PCSK9 功能获得突变联合 0.75% 高胆固醇饮食 16 周建立动脉粥样硬化模型。结果显示 Adcy9 失活使主动脉粥样硬化减少 65%,并改善内皮功能与自主神经张力,但这些保护作用在 CETP 存在时消失。

要点

  • Adcy9 失活使主动脉粥样硬化减少 65%,但仅在无 CETP 活性时成立。
  • Adcy9 失活减少斑块巨噬细胞积聚与增殖,并改善内皮依赖性舒张。
  • CETP 存在时 Adcy9 失活的抗动脉粥样硬化及代谢效应均消失。

核心结论

  • Adcy9 失活可抗动脉粥样硬化,但该保护作用仅在没有 CETP 活性时出现。

研究设计与样本

  • 研究使用 Adcy9 失活小鼠与野生型小鼠,分别在有或无 CETP 转基因背景下,接受 AAV8 表达 PCSK9 功能获得突变及 0.75% 胆固醇饮食 16 周。

主要发现

  • Adcy9 失活小鼠主动脉粥样硬化较野生型减少 65%(P<0.01)。
  • Adcy9 失活小鼠斑块中 CD68 阳性巨噬细胞积聚与增殖均减少(两者 P<0.05)。
  • Adcy9 失活小鼠股动脉内皮依赖性舒张改善(对比野生型 P<0.01),一氧化氮、环氧合酶及内皮依赖性超极化通路均参与(均 P<0.01)。
  • Adcy9 失活小鼠主动脉内皮对脾细胞黏附显著少于野生型(P<0.05)。
  • Adcy9 失活小鼠在高胆固醇饮食下体重增加更多且全身脂肪组织体积增加(两者 P<0.01),饲料效率升高(P<0.01),伴 RR 间期延长(P<0.05)及夜间心率变异性改善(P=0.0572)。

关键数值与推荐

  • 在 CETP 转基因背景下,Adcy9 失活对动脉粥样硬化、内皮功能、体重增加、脂肪组织体积及饲料效率的效应均消失(对比 CETP 转基因野生型 P>0.05)。

临床怎么用

  • 提示 ADCY9 基因型与 CETP 活性状态可能影响心血管保护策略的个体化评估。

局限性

  • 研究为小鼠模型,采用 AAV8-PCSK9 功能获得突变联合高胆固醇饮食诱导动脉粥样硬化,结果向人群外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the CETP (cholesteryl ester transfer protein) inhibitor dalcetrapib on cardiovascular events and atherosclerosis imaging. The underlying mechanisms responsible for the interactions between ADCY9 and CETP activity have not yet been determined. METHODS: Adcy9-inactivated ( Adcy9Gt/Gt) and wild-type (WT) mice, that were or not transgenic for the CETP gene (CETPtg Adcy9Gt/Gt and CETPtg Adcy9WT), were submitted to an atherogenic protocol (injection of an AAV8 [adeno-associated virus serotype 8] expressing a PCSK9 [proprotein convertase subtilisin/kexin type 9] gain-of-function variant and 0.75% cholesterol diet for 16 weeks). Atherosclerosis, vasorelaxation, telemetry, and adipose tissue magnetic resonance imaging were evaluated. RESULTS: Adcy9Gt/Gt mice had a 65% reduction in aortic atherosclerosis compared to WT ( P<0.01). CD68 (cluster of differentiation 68)-positive macrophage accumulation and proliferation in plaques were reduced in Adcy9Gt/Gt mice compared to WT animals ( P<0.05 for both). Femoral artery endothelial-dependent vasorelaxation was improved in Adcy9Gt/Gt mice (versus WT, P<0.01). Selective pharmacological blockade showed that the nitric oxide, cyclooxygenase, and endothelial-dependent hyperpolarization pathways were all responsible for the improvement of vasodilatation in Adcy9Gt/Gt ( P<0.01 for all). Aortic endothelium from Adcy9Gt/Gt mice allowed significantly less adhesion of splenocytes compared to WT ( P<0.05). Adcy9Gt/Gt mice gained more weight than WT with the atherogenic diet; this was associated with an increase in whole body adipose tissue volume ( P<0.01 for both). Feed efficiency was increased in Adcy9Gt/Gt compared to WT mice ( P<0.01), which was accompanied by prolonged cardiac RR interval ( P<0.05) and improved nocturnal heart rate variability ( P=0.0572). Adcy9 inactivation-induced effects on atherosclerosis, endothelial function, weight gain, adipose tissue volume, and feed efficiency were lost in CETPtg Adcy9Gt/Gt mice ( P>0.05 versus CETPtg Adcy9WT). CONCLUSIONS: Adcy9 inactivation protects against atherosclerosis, but only in the absence of CETP activity. This atheroprotection may be explained by decreased macrophage accumulation and proliferation in the arterial wall, and improved endothelial function and autonomic tone.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Rautureau Y, Deschambault V, Higgins MÈ, et al. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein). Circulation. 2018. PMID: 29674325. doi:10.1161/CIRCULATIONAHA.117.031134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。